Hormone Replacement Therapy: Tibolone

Hormone Replacement Therapy: Tibolone

User Options

Hover over an icon for more information

Additional Topics Details for this Page

Article Count - 1
Cumulative Knowledge - 10

Advanced Database Options

Limit Articles Displayed by the Following Study Types

What is Cumulative Knowledge?

Cumulative Knowledge is determined by ascribing a numerical value to the various study types weighted in descending order as follows: (1) Meta-Analysis; (2) Human Study; (3) Human: Case Study; (4) Animal: Transgenic; (5) Animal; (6) In Vitro; (7) Review; and (8) Commentary.

Click here for a more thorough explanation.

Quick Summary: 1 associated Diseases

Name	Cumulative Knowledge	Article Count	Focus Articles
Breast Cancer	10	1	Log in \| Sign up

Quick Summary: 1 associated Adverse Pharmacological Actions

Name	Cumulative Knowledge	Article Count	Focus Articles
Carcinogenic	10	1	Log in \| Sign up

Currently Viewing Free Sample of Member Only Features

Although all 19,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 2 rows, of the membership feature called "Cumulative Knowledge" (learn more).

The Focus Article Feature is not enabled.

Upgrading to the Member role gives you access to unlimited rows of Cumulative Knowledge data.

To Participate

Click here to login
Click here to create an account

View the Evidence: Problem Substances

Tibolone increases bone mineral density but also relapse in breast cancer survivors. This increase in breast cancer was not seen in those women with low BMD.

Click here to read the entire abstract

Pubmed Data : Breast Cancer Res. 2012 Jan 17 ;14(1):R13. Epub 2012 Jan 17. PMID: 22251615

Article Published Date : Jan 17, 2012

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2354) : AC(621)

Anti Therapeutic Actions : High Bone Density : CK(142) : AC(16)

Problem Substances : Hormone Replacement Therapy : CK(81) : AC(6), Hormone Replacement Therapy: Tibolone : CK(10) : AC(1)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version
Send to friend
PDF version